Skip to main content
Equibles

Eversept Partners, LP

Position in EDIT — Editas Medicine, Inc.

CIK 1697013 NEW YORK, NY
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,486,541
+$767,972 QoQ
Shares Held
458,809
+57.7% QoQ
Ownership
0.299%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#36
of 216 holders
Holding Since
Sep 2021
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Derivatives in EDIT

reported options exposure · as of Sep 30, 2021
CallValue
$3,697,200
CallShares
90,000
PutValue
$2,054,000
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. EDIT ranks #55 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 913,880 $121,783,648
2 VERA
Vera Therapeutics, Inc.
 2,212,770 $94,949,960
3 CLDX
Celldex Therapeutics, Inc.
 1,785,941 $66,454,864
4 SNDX
Syndax Pharmaceuticals Inc
 2,798,210 $61,168,870
5 IONS
Ionis Pharmaceuticals Inc
 664,684 $52,702,794
6 TVTX
Travere Therapeutics, Inc.
 798,973 $45,389,656
7 PCVX
Vaxcyte, Inc.
 629,952 $36,619,109
8 GERN
Geron Corp
 18,717,422 $23,958,300

All Filings in EDIT

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,486,541 458,809
2026-03-31 $718,569 290,919
2025-12-31 $596,383 290,919
2021-09-30 $2,054,000 50,000
2021-09-30 $3,697,200 90,000